GlassScriptPhysician profile
Stanton L Longenecker
NPI 1821092271
$330,364.30
in general payments reported to CMS, 2019-2025
26 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $121K · 2021: $88K · 2022: $4,764 · 2023: $8,589 · 2024: $1,085 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,250 · Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,250.00 |
| Food and Beverage | $587.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $273,660.83 | 2019-2021 | |
| Uoc USA INC | $52,617.88 | 2019-2025 | U2, U-Motion II and Utf |
| Medacta USA, INC. | $1,698.99 | 2020 | |
| Nextstep Arthropedix, LLC | $727.96 | 2019-2021 | |
| Pfizer INC. | $380.85 | 2019-2025 | |
| Maxx Orthopedics, INC. | $232.77 | 2019 | |
| Total Joint Orthopedics, INC. | $139.40 | 2019 | |
| Vericel Corporation | $128.82 | 2019 | |
| Biocomposites INC | $126.08 | 2019-2021 | |
| Anika Therapeutics, INC. | $100.58 | 2020 | |
| Next Science LLC | $96.31 | 2020 | |
| Lima USA, INC. | $80.38 | 2021 | |
| Pacira Therapeutics, INC. | $59.98 | 2019 | |
| Zimmer Biomet Holdings, INC. | $48.58 | 2022-2023 | Mymobility Platform, Persona |
| Bioventus LLC | $40.95 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $39.06 | 2024 | |
| Smith+Nephew, INC. | $29.56 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $26.38 | 2019 | |
| Stryker Corporation | $22.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.00 | 2020 | |
| Moximed, INC | $19.50 | 2025 | Misha Knee System, Small, Left |
| Depuy Synthes Sales INC. | $15.48 | 2020 | |
| Medtronic USA, INC. | $14.71 | 2019 | |
| Orthofix Medical, INC. | $13.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.92 | 2019 | |
| Convatec INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanton Longenecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.